AGY Share Price

Open 27.25 Change Price %
High 27.80 1 Day 0.00 0.00
Low 26.85 1 Week -1.00 -3.54
Close 27.25 1 Month 3.13 12.98
Volume 395685 1 Year 1.00 3.81
52 Week High 31.00
52 Week Low 17.25
AGY Important Levels
Resistance 2 28.13
Resistance 1 27.77
Pivot 27.30
Support 1 26.73
Support 2 26.37
LON UK Most Active Stocks
LLOY 67.41 0.69%
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
HER 0.06 0.00%
HER 0.06 0.00%
BKIR 0.25 -3.85%
IRG 0.40 -9.09%
IRG 0.40 -9.09%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
BAF 80.00 77.78%
BAF 80.00 77.78%
BAF 80.00 77.78%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
PFLM 5.75 64.29%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
BHR 0.02 -33.33%
NBR 0.25 -24.24%
More..

ALLERGY THERAPEUT (LON: AGY)

AGY Technical Analysis 3
As on 26th Apr 2017 AGY Share Price closed @ 27.25 and we RECOMMEND Buy for LONG-TERM with Stoploss of 22.58 & Buy for SHORT-TERM with Stoploss of 26.83 we also expect STOCK to react on Following IMPORTANT LEVELS.
AGY Target for April
1st Target up-side 30.52
2nd Target up-side 32.81
3rd Target up-side 35.1
1st Target down-side 23.98
2nd Target down-side 21.69
3rd Target down-side 19.4
ALLERGY THERAPEUT ( LON UK Symbol : AGY )
Sector : N/A And Other Stocks in Same Sector
AGY Other Details
Segment EQ
Market Capital 0.00
Sector
Industry
Offical website
AGY Address
AGY
AGY Latest News
Panmure Gordon Reiterates "Buy" Rating for Allergy Therapeutics plc (AGY)   The Cerbat Gem   - 24th Apr 17
Allergy Therapeutics plc (AGY) Price Target Raised to GBX 45 at Numis ...   The Cerbat Gem   - 20th Apr 17
Allergy Therapeutics plc (AGY) Receives "Buy" Rating from FinnCap   The Cerbat Gem   - 18th Apr 17
Market Risers: 3i Group plc, Allergy Therapeutics plc, Ashtead Group plc   DirectorsTalk Interviews   - 29th Mar 17
Allergy Therapeutics confident of further growth   Proactive Investors UK   - 29th Mar 17
Allergy Therapeutics recruits first patients to its phase III birch trial   Proactive Investors UK   - 16th Mar 17
Allergy Therapeutics peanut allergy vaccine to move into phase I trials after ...   Proactive Investors UK   - 01st Feb 17
Allergy Therapeutics' revenues rising across hay fever portfolio   Proactive Investors UK   - 19th Jan 17
Allergy Therapeutics' malaria boost   Proactive Investors UK   - 10th Oct 16
Allergy Therapeutics PLC outperforming the market   Proactive Investors UK   - 08th Mar 16
Interactive Technical Analysis Chart ALLERGY THERAPEUT ( AGY LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on ALLERGY THERAPEUT
AGY Business Profile
N/A